Edesa Biotech EDSA Income Statement (2013-2026)

NASDAQ EDSA
$4.72 -0.01 (-0.21%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Edesa Biotech Quarterly Income Statement

Periods 49 quarters
Latest Jun 2026

Edesa Biotech reported net income of -$5.41M for the quarter ended Jun 2026. This income statement covers 49 quarters of results from Aug 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Aug2013 Dec2013 Aug2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
1.89M1.90M1.93M2.21M2.21M2.38M2.76M2.87M2.98M3.08M3.16M3.22M3.25M3.25M3.47M5.31M7.02M5.68M8.33M9.63M
Revenue & cost
Revenue
Gross Profit
Operating items
Research & DevelopmentR&D
4.46M4.13M3.95M3.04M4.55M1.79M1.36M1.46M1.03M0.95M0.70M1.18M0.90M0.10M1.02M0.48M0.94M1.23M1.12M3.96M
Selling, General & AdministrativeSG&A
1.61M1.36M1.21M1.53M1.25M1.04M1.02M0.95M1.04M1.42M1.15M1.04M1.04M0.90M0.88M1.15M0.96M1.24M1.22M1.56M
Other Operating ExpensesOther Opex
Operating ExpensesOpex
6.07M5.48M5.16M4.58M5.80M2.84M2.38M2.41M2.06M2.37M1.86M2.22M1.93M1.00M1.90M1.64M1.90M2.47M2.34M5.52M
Operating IncomeOp. Inc
-6.07M-5.48M-5.16M-4.58M-5.80M-2.84M-2.38M-2.41M-2.06M-2.37M-1.86M-2.22M-1.93M-1.00M-1.90M-1.64M-1.90M-2.47M-2.34M-5.52M
EBIT
-6.07M-5.48M-5.16M-4.58M-5.80M-2.84M-2.38M-2.41M-2.06M-2.37M-1.86M-2.22M-1.93M-1.00M-1.90M-1.64M-1.90M-2.47M-2.34M-5.52M
Non-operating items
Non Operating Interest Expenses
4.58M
Interest & Investment IncomeInt & Inv Inc
0.00M0.01M0.01M0.00M0.02M0.04M0.05M0.09M0.08M0.07M0.06M0.04M0.03M0.02M0.00M265.00572.0055.0047.00275.00
Other Non Operating IncomeOther Non Op Inc.
0.00M10.28M-0.00M0.00M-0.01M-0.01M-0.01M-0.01M-0.00M-0.19M-0.00M0.01M-0.00M-0.07M-0.02M-0.00M-0.03M0.27M-0.01M0.00M
Non Operating IncomeNon Op. Inc.
1.31M1.80M0.78M0.01M0.01M0.02M0.04M0.08M0.08M0.65M0.18M0.36M0.26M0.04M0.28M0.05M0.15M0.24M0.09M0.11M
Net income details
EBT
-4.76M-3.69M-5.16M-4.57M-5.79M-2.81M-2.33M-2.33M-1.98M-1.72M-1.80M-1.86M-1.67M-0.96M-1.90M-1.59M-1.75M-2.23M-2.34M-5.41M
Tax ProvisionsTaxes
-3.54M800.00-4.65M800.00-2.22M800.00-1.64M800.00-1.91M
Profit After TaxPAT
-4.76M-3.69M-4.38M-4.57M-5.79M-2.82M-2.36M-2.33M-1.98M-1.75M-1.68M-1.87M-1.67M-0.98M-1.62M-1.65M-1.75M-2.24M-2.30M-5.41M
Equity Income
Income from Continuing OperationsIncome (Continuing)
-4.76M-0.15M-5.16M-4.57M-5.79M1.84M-2.33M-2.33M-1.98M0.50M-1.80M-1.86M-1.67M0.67M-1.90M-1.59M-1.75M-0.32M-2.34M-5.41M
Consolidated Net IncomeConsol Net Inc.
-4.76M-0.15M-5.16M-4.57M-5.79M1.84M-2.33M-2.33M-1.98M0.50M-1.80M-1.86M-1.67M0.67M-1.90M-1.59M-1.75M-0.32M-2.34M-5.41M
Income towards Parent CompanyParent Net Inc
-4.76M-0.15M-5.16M-4.57M-5.79M1.84M-2.33M-2.33M-1.98M0.50M-1.80M-1.86M-1.67M0.67M-1.90M-1.59M-1.75M-0.32M-2.34M-5.41M
Net Income towards Common StockholdersNet Income
-4.76M-0.15M-5.16M-4.57M-5.79M1.84M-2.33M-2.33M-1.98M0.50M-1.80M-1.86M-1.67M0.67M-1.90M-1.59M-1.75M-0.32M-2.34M-5.41M
Additional items
EPS (Basic)
-2.51-0.09-2.70-2.31-2.620.77-0.89-0.82-0.680.17-0.57-0.58-0.520.21-0.57-0.30-0.25-0.06-0.29-0.60
EPS (Diluted)
-158.53-4.97-171.72-152.19-192.7561.18-77.57-77.75-66.1116.62-59.84-62.00-55.5622.44-63.19-52.97-58.27-10.59-77.98-180.12
Shares Outstanding
1.89M1.73M1.91M1.98M2.21M2.38M2.63M2.85M2.93M2.86M3.13M3.19M3.22M3.20M3.35M5.31M7.02M5.68M7.97M9.01M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
EBITDA
-6.07M-5.48M-5.16M-4.58M-5.80M-2.84M-2.38M-2.41M-2.06M-2.37M-1.86M-2.22M-1.93M-1.00M-1.90M-1.64M-1.90M-2.47M-2.34M-5.52M
Interest ExpensesInt Expense
4.58M
Tax Rate
95.95-0.02165.28-0.03129.00-0.04170.03-0.0585.74